The Caledonian-Record

Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion …

Just as we redefined what is possible in cystic fibrosis, our ambition is to transform the future for people living with ...